John Tavares Makes Obvious Admission About Maple Leafs Extension
John Tavares will play for the Toronto Maple Leafs through the 2028–29 season, and according to the captain himself, the financial terms he agreed to weren't the most lucrative offered to him.
Advertisement
Tavares officially announced his four-year, $17.52 million extension on Friday. The deal includes a full no-move clause through June 2027 and a modified, five-team no-trade clause active for the final two seasons of the contract.
The 34-year-old forward made the reveal via his foundation's Instagram account.
'Coming to Toronto 7 years ago has been better than I ever anticipated," Tavares wrote. "I'm thrilled to announce that I'm committed to four more years! My family and I are excited to continue our journey here in Toronto.'
During a Zoom call with reporters after the extension became official, Tavares admitted he could have earned significantly more on the open market.
Advertisement
'Even though I left some money out there, I've done pretty well,' Tavares said. 'I'm still doing pretty well, and I get to play for an amazing club and a great city, a place where I'm from, and a team that's got a real opportunity to win.'
According to TSN's Pierre LeBrun, one offer topped out at two years and $16 million. Still, Tavares made it clear money wasn't the deciding factor.
Toronto Maple Leafs center John Tavares (91) warms up.Kim Klement-Imagn Images
Meanwhile, general manager Brad Treliving praised Tavares for setting the tone in negotiations.
"We would all agree there was going to be an opportunity to make a lot more money elsewhere," Treliving said. "His focus was on staying here. His work, his commitment, and his desire steered the process on this negotiation."
Advertisement
"Full marks and credit to John and his representatives, and on our side, Brandon Pridham. It was a team effort, and it was led by John."
Related: Paul Bissonnette Hears of 'Agreed-Upon' Brad Marchand-Maple Leafs Deal
Related: 'We're Fortunate': Maple Leafs' GM Sounds Off on Mitch Marner
This story was originally reported by Athlon Sports on Jun 28, 2025, where it first appeared.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
19 minutes ago
- Yahoo
'Could have hired anyone': Tennis world explodes over Jannik Sinner announcement
Alex de Minaur has made a bright start to his North American hard-court campaign, amid a golden opportunity for the Aussie tennis star to climb the rankings before the US Open. The World No.13 was too good for Yunchaokete Bu at the Citi Open in Washington on Wednesday, winning 7-6 (5) 6-2. The Aussie made a somewhat slow start and was pushed to a tiebreaker in the first set, but showed his class in the second by running away with it. The win was de Minaur's first since Wimbledon, where he lost to Novak Djokovic in the fourth round. He'll now play Czech 11th seed Jiri Lehecka in the Round of 16, with a golden opportunity to rise in the ATP rankings. De Minaur doesn't have any points to defend heading into the US Open because he didn't play any of the lead-up events last year. The Aussie was sidelined by a hip injury he sustained at Wimbledon in 2024, meaning he didn't play between the grass and hard-court grand slams. That means he doesn't have any rankings points to defend this year, and any wins he records will see him rise in the standings. With Jannik Sinner, Carlos Alcaraz, Novak Djokovic and Jack Draper all withdrawing from next week's Masters 1000 event in Toronto, de Minaur has a chance to gain ground on his rivals. With a deep run in Washington and Toronto, he can surge back into the top-10 and potentially get himself an all-important top-eight seeding for the US Open. That would ensure he doesn't face anyone higher than him in the rankings until the quarter-finals. 'It was somewhat difficult at the start of the year and mentally taxing knowing that I had zeros on my ranking because I missed three Masters [also Shanghai],' De Minaur said before the match on Wednesday. 'I knew it would be important to put myself in a good position for the back end of the year when I have little to defend, giving hope that I could gain some serious points and momentum and build on the ranking. So going into the tail end of the year, I'm excited for the opportunity and hoping I can play good tennis and take care of my chances.' Jannik Sinner re-appoints trainer Umberto Ferrara Meanwhile, World No.1 Sinner has stunned the tennis world after announcing he's reunited with former fitness coach Umberto Ferrara. Sinner parted ways with Ferrara and physiotherapist Giacomo Naldi last year after twice testing positive for banned substance clostebol in March 2024. The banned substance entered Sinner's system after Naldi applied an over-the-counter spray to a cut on his own hand before giving the World No.1 a massage without gloves on. Ferrara had given the spray to Naldi, and they both paid the price when Sinner opted to part ways with them. But Sinner's team announced on Wednesday that Ferrara is returning with immediate effect. "The decision has been made in alignment with Jannik's management team as part of ongoing preparations for upcoming tournaments, including the Cincinnati Open and US Open," a statement from Sinner's team said. "Umberto has played an important role in Jannik's development to date, and his return reflects a renewed focus on continuity and performance at the highest level." RELATED: Jannik Sinner triumph could force Aussie coach to backflip on exit call Flood of support after tennis rocked by news about Wimbledon finalist Sinner had explained his decision to part ways with Ferrara and Naldi at the US Open last year. "Now, because of these mistakes, I'm not feeling that confident to continue with them," he said. "I was struggling a lot in the last months. I was waiting for the result. The only thing I need right now is some clean air." Tennis world reacts to Jannik Sinner announcement In February, Sinner cut a deal with the Court of Arbitration for Sport to take a three-month ban, which many thought was very light punishment despite the fact he ingested the banned substance inadvertently. He returned right in time for the French Open, finishing runner-up to Carlos Alcaraz before turning the tables on the World No.2 in the Wimbledon final. The optics of bringing Ferrara back onto his team have raised eyebrows around the tennis world. Aussie great Paul McNamee wrote on social media: "Jannik Sinner rehiring Umberta Ferrara has to be up there as one of the most astonishing PR moves in tennis history. You can afford to hire anyone in the world. Why oh why Jannik?" If he stands by his belief that it was an honest mistake like they've claimed from the beginning, why wouldn't he want to rehire him? Refusing to rehire him because a few idiots on twitter will cry would be silly. Willingness to rehire him more likely confirms there was no… — Mike Gerasimo (@SIGerasimo) July 23, 2025 He got the same doc back 😂😂😂 we have been played ladies and gentlemen 🥔🥔🥔🥔🥔 — Nicholas Kyrgios (@NickKyrgios) July 23, 2025 This is really crazy. I don't get how even the most moderate and forgiving critics of the Sinner Saga (like me) can possibly look at this news and not think something is off. Didn't Sinner accept a 3-month BAN from playing tennis because his team, which included Ferrara, made a… — Chris Nolen (@LoveAsInZero) July 23, 2025 with agencies
Yahoo
19 minutes ago
- Yahoo
Altius Completes Sale of 2/3 of its Silicon Gold 1.5% NSR to Franco-Nevada
Altius Retains 0.5% NSR interest as Long-Term Portfolio Component ST. JOHN'S, Newfoundland and Labrador, July 23, 2025--(BUSINESS WIRE)--Altius Minerals Corporation (TSX: ALS) (OTCQX: ATUSF) Altius Minerals Corporation ("Altius") is pleased to announce that Altius Royalty Corporation ("ARC"), a wholly-owned subsidiary of Altius, has completed the sale of a 1% NSR royalty covering the Silicon and Merlin gold deposit discoveries in Nevada ("1% NSR Silicon Royalty") to a wholly owned subsidiary of Franco-Nevada Corporation ("Franco-Nevada") (TSX & NYSE: FNV) ("The Transaction"), pursuant to a royalty purchase agreement entered into by ARC and Franco-Nevada (the "Agreement"). ARC will continue to hold a remaining 0.5% NSR royalty interest in Silicon (recently renamed to the Arthur Gold Project by AngloGold Ashanti plc ("AGA") as a long-term component of its diversified portfolio. The purchase price for the 1% NSR Silicon Royalty interest is US$ 275 million (~ C$ 375 million) comprised of US$ 250 million in upfront cash paid at closing and a further payment of US $25 million in cash payable upon the conclusion of an ongoing arbitration process that confirms the area subject to the royalty under final award to be consistent with Altius's interpretation of the partial award of the arbitration tribunal that was issued and reported on earlier this year. The Board of Directors of Altius has received a fairness opinion from Cormark Securities Inc. which opinion concluded that, based upon and subject to the assumptions made, procedures followed, matters considered, limitations and qualifications set out therein, the consideration to be received by ARC pursuant to the Transaction is fair, from a financial point of view, to ARC. Brian Dalton, CEO of Altius commented, "We are pleased to partner with Franco-Nevada on this royalty, which encompasses AGA's world-class Silicon and Merlin gold deposit discoveries in Nevada, as well as extensive areas of prospective surrounding land. The Transaction crystallizes significant value for shareholders while further demonstrating the ability of Altius's Project Generation business to amplify the return profile of its overall royalty investment portfolio. The decision to retain a third of our Silicon royalty interest also provides continuing growth exposure to this emerging gold district, while confirming the addition of precious metals as a long-term, well-balanced component of our shareholder's diversified royalty portfolio. We now look forward to the ability to explore a wider set of capital allocation and deployment opportunities, facilitated by a considerably strengthened balance sheet and liquidity profile, and to further growing shareholder value." Anticipated Benefits to Altius Shareholders Capital Allocation Opportunities Cash, after taxes and fees, expected to increase to more than C$ 360 million (assumes up front and further payment proceeds from this Transaction and also from the recent acquisition of Orogen Royalties Inc. by Triple Flag Precious Metals Corp.) Total liquidity increased to more than C$ 540 million (including C$ 116 million available under a revolving credit facility and C$ 62.5 million potentially available under an accordion feature) Creates enhanced flexibility to evaluate external M&A opportunities while limiting equity level dilution of existing assets and the embedded growth potential of our portfolio Improves ability to opportunistically increase per share exposure to existing royalty interests through share repurchases Retained Royalty Exposure Continuing optionality exposure to gold resource growth1 from current ~16 Moz resource estimate at the Arthur Gold Project, as AGA continues aggressive exploration and delineation drilling programs and the reporting of encouraging results Achieves rebalance of commodity exposures while confirming precious metals and another tier-1 quality royalty as components of Altius's long-term, diversified portfolio. For further information, please see the updated Altius corporate presentation posted to the website at 1 See Expanded Silicon Project Update presentation Financial and Legal Advisors Cormark Securities Inc. is acting as financial advisor to Altius. Stikeman Elliott LLP is acting as legal counsel to Altius and ARC. About Altius Altius's strategy is to create per share growth through a diversified portfolio of royalty assets that relate to long life, high margin operations. This strategy further provides shareholders with exposures that are well aligned with global growth trends including increasing electricity based market share within energy usage, global infrastructure build and refurbishment growth, increased EAF based steelmaking, steadily increasing agricultural fertilizer requirements and the enhanced appetite for financial asset diversification through precious metals ownership. These macro-trends each hold the potential to cause higher demand for many of Altius's commodity exposures including potash, high purity iron ore, renewable energy, base metals, and gold . In addition, Altius runs a successful Project Generation business that originates mineral projects for sale to developers in exchange for royalties and that has a demonstrated track record of driving outsized direct returns from its overall royalty investment portfolio. Altius has 46,315,304 common shares issued and outstanding that are listed on Canada's Toronto Stock Exchange. It is a member of both the S&P/TSX Small Cap and S&P/TSX Global Mining Indices and the S&P/TSX Canadian Dividend Aristocrats Index. Forward Looking Information This news release contains forward-looking information. The statements are based on reasonable assumptions and expectations of management and Altius provides no assurance that actual events will meet management's expectations. The information in this news release about the any anticipated benefits of the transaction to Altius Shareholders, timing and results of the ongoing arbitration process in respect of the Silicon royalty and possibility of ARC being paid contingent consideration of US$25 million following conclusion thereof, and any other information herein that is not a historical fact may be forward looking information. In certain cases, forward-looking information may be identified by such terms as "anticipates", "believes", "could", "estimates", "expects", "may", "shall", "will", or "would". Although Altius believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those projected. Readers should not place undue reliance on forward-looking information. Altius does not undertake to update any forward-looking information contained herein except in accordance with securities regulations. View source version on Contacts For further information, please contact:Flora WoodEmail: Fwood@ Tel: 1.877.576.2209Direct: 1.416.346.9020 Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
19 minutes ago
- Yahoo
ASP Isotopes Inc. Announces Pricing of $60 Million Underwritten Registered Direct Offering of Common Stock
WASHINGTON, July 23, 2025 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. NASDAQ: ASPI ("ASP Isotopes' or the 'Company'), today announced the pricing of an underwritten registered direct offering of 7,500,000 shares of its common stock at a price of $8.00 per share to a single fundamental institutional investor. The gross proceeds from the offering, before deducting underwriting discounts and commissions and offering expenses, are expected to be approximately $60.0 million. The offering is expected to close on or about July 25, 2025, subject to the satisfaction of customary closing conditions. Cantor and Canaccord Genuity acted as joint book-running managers for the offering. Ocean Wall Limited acted as financial advisor. The net proceeds of this offering are expected to be used for general corporate purposes, including working capital, operating expenses, and capital expenditures. The offering is being made pursuant to a shelf registration statement on Form S-3 that was previously filed with and declared effective by the Securities and Exchange Commission ('SEC') and a related registration statement that was filed with the SEC pursuant to Rule 462(b) under the Securities Act of 1933 (and became automatically effective upon filing). This offering is being made only by means of a prospectus supplement and the accompanying prospectus that form a part of the registration statement. A final prospectus supplement relating to and describing the terms of the offering will be filed with the SEC and will be available on the SEC's website at When available, copies of the final prospectus supplement and accompanying prospectus relating to these securities may also be obtained by sending a request to: Cantor Fitzgerald & Co., Attention: Capital Markets, 110 East 59th Street, 6th Floor, New York, New York 10022, or by email at prospectus@ or Canaccord Genuity LLC, Attention: Syndication Department, 1 Post Office Square, 30th Floor, Boston, MA 02109, or by email at prospectus@ This press release does not constitute an offer to sell or a solicitation of an offer to buy any of these securities, nor will there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale is not permitted. About ASP Isotopes Inc. ASP Isotopes Inc. is a development stage advanced materials company dedicated to the development of technology and processes to produce isotopes for use in multiple industries. The Company employs proprietary technology, the Aerodynamic Separation Process ('ASP technology'). The Company's initial focus is on producing and commercializing highly enriched isotopes for the healthcare and technology industries. The Company also plans to enrich isotopes for the nuclear energy sector using Quantum Enrichment technology that the Company is developing. The Company has isotope enrichment facilities in Pretoria, South Africa, dedicated to the enrichment of isotopes of elements with a low atomic mass (light isotopes). There is a growing demand for isotopes such as Silicon-28, which will enable quantum computing, and Molybdenum-100, Molybdenum-98, Zinc-68, Ytterbium-176, and Nickel-64 for new, emerging healthcare applications, as well as Chlorine-37, Lithium-6, and Uranium-235 for green energy applications. The ASP Technology (Aerodynamic Separation Process) is ideal for enriching low and heavy atomic mass molecules. For more information, please visit Forward Looking Statements This press release contains 'forward-looking statements' within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations, and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy, and other future conditions. Forward-looking statements can be identified by words such as 'believes,' 'plans,' 'anticipates,' 'expects,' 'estimates,' 'projects,' 'will,' 'may,' 'might,' and words of a similar nature. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks, and changes in circumstances that are difficult to predict, many of which are outside our control. Our actual results, financial condition, and events may differ materially from those indicated in the forward-looking statements based upon a number of factors. Forward-looking statements are not a guarantee of future performance or developments. You are strongly cautioned that reliance on any forward-looking statements involves known and unknown risks and uncertainties. Therefore, you should not rely on any of these forward-looking statements. There are many important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements, including: risks and uncertainties related to the satisfaction of customary closing conditions related to the public offering; the intended use of net proceeds from the public offering; the impact of general economic, industry or political conditions in the United States or internationally; the failure to obtain necessary regulatory approvals and third party consents for the proposed acquisition of Renergen; disruption from the proposed acquisition of Renergen making it more difficult to maintain business and operational relationships; significant transaction costs and unknown liabilities related to the proposed acquisition of Renergen; litigation or regulatory actions related to the proposed acquisition of Renergen; the outcomes of various strategies and projects undertaken by the Company; the potential impact of laws or government regulations or policies in South Africa, the United Kingdom or elsewhere; our reliance on the efforts of third parties; our ability to complete the proposed the construction and commissioning of our enrichment plant(s) or to commercialize isotopes using the ASP technology or the Quantum Enrichment Process; our ability to obtain regulatory approvals for the production and distribution of isotopes; the financial terms of any current and future commercial arrangements; our ability to complete certain transactions and realize anticipated benefits from acquisitions and contracts; dependence on our Intellectual Property (IP) rights, certain IP rights of third parties; the competitive nature of our industry; and the factors disclosed in Part I, Item 1A. 'Risk Factors' of the company's Annual Report on Form 10-K for the fiscal year ended December 31, 2024 and any amendments thereto and in the company's subsequent reports and filings with the U.S. Securities and Exchange Commission. Any forward-looking statement made by us in this press release is based only on information currently available to us and speaks only as of the date on which it is made. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise. No information in this press release should be interpreted as an indication of future success, revenues, results of operation, or stock price. All forward-looking statements herein are qualified by reference to the cautionary statements set forth herein and should not be relied upon. Contacts Jason Assad– Investor relationsEmail: Jassad@ 561-709-3043
